How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Infectious Disease Archives

Ebola Bundibugyo Virus Disease in the Democratic Republic of the Congo and Uganda – Level 2 – Level 2 – Practice Enhanced Precautions – Travel Health Notices | Travelers’ Health

Bundibugyo virus disease (BVD) Bundibugyo virus disease (BVD) is a rare and potentially deadly type of

July 12, 2026 No Comments

Korea University College of Medicine selected as the lead institution for hantavirus vaccine development project

The Vaccine Innovation Center at Korea University College of Medicine has been selected by the

July 11, 2026 No Comments

Early Release – Virulence of Burkholderia pseudomallei Strains from Western Hemisphere and Africa in Mice – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Burkholderia pseudomallei, a gram-negative facultative intracellular bacterium, causes the disease melioidosis and is critical to

July 11, 2026 No Comments

Early Release – Use of Salmonella enterica Serovar Typhi Hemolysin E and Lipopolysaccharide IgA to Identify Enteric Fever Cases, South Asia – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as

July 11, 2026 No Comments

Communicable disease threats report, 6

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health

July 10, 2026 No Comments

Early Release – Serologic Evidence of Hantavirus Exposure in Humans, Italy, 2004–2018 – Volume 32, Number 9—September 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

July 10, 2026 No Comments

U.S. citizens on hantavirus cruise ship monitored at Nebraska Medicine

A room in the National Quarantine Unit. Photo courtesy Nebraska Medicine In May, U.S. passengers

July 10, 2026 No Comments

This frog bacterium wiped out cancer tumors in mice with a single dose

Scientists at the Japan Advanced Institute of Science and Technology (JAIST) have identified a naturally

July 10, 2026 No Comments

Early Release – Use of Salmonella enterica Serovar Typhi Hemolysin E and Lipopolysaccharide IgA to Identify Enteric Fever Cases, South Asia – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as

July 10, 2026 No Comments

Quick takes: Michigan cyclosporiasis spike, NYC Legionnaire’s cluster, drop in US PhD admissions

The number of cases in the cyclosporiasis outbreak in southeastern Michigan has grown to 700.

July 10, 2026 No Comments

Ebola Bundibugyo Virus Disease in the Democratic Republic of the Congo and Uganda – Level 2 – Level 2 – Practice Enhanced Precautions – Travel Health Notices | Travelers’ Health

Korea University College of Medicine selected as the lead institution for hantavirus vaccine development project

Early Release – Virulence of Burkholderia pseudomallei Strains from Western Hemisphere and Africa in Mice – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Early Release – Use of Salmonella enterica Serovar Typhi Hemolysin E and Lipopolysaccharide IgA to Identify Enteric Fever Cases, South Asia – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Communicable disease threats report, 6

Early Release – Serologic Evidence of Hantavirus Exposure in Humans, Italy, 2004–2018 – Volume 32, Number 9—September 2026 – Emerging Infectious Diseases journal

U.S. citizens on hantavirus cruise ship monitored at Nebraska Medicine

This frog bacterium wiped out cancer tumors in mice with a single dose

Early Release – Use of Salmonella enterica Serovar Typhi Hemolysin E and Lipopolysaccharide IgA to Identify Enteric Fever Cases, South Asia – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Quick takes: Michigan cyclosporiasis spike, NYC Legionnaire’s cluster, drop in US PhD admissions

Schedule an Appointment

Quick Links

Patient Forms

Contact Us